Elucidating cellular mechanisms underlying neurodegeneration
阐明神经变性的细胞机制
基本信息
- 批准号:10647869
- 负责人:
- 金额:$ 57.57万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-06-17 至 2027-05-31
- 项目状态:未结题
- 来源:
- 关键词:Adaptor Signaling ProteinAdolescentAlzheimer&aposs DiseaseAmino AcidsAntisense OligonucleotidesAutophagocytosisAutophagosomeAxonAxonal TransportBehavioralCell Culture TechniquesCell NucleusCell physiologyCellsCentral Nervous SystemClinicComplexCytoskeletonDataDegradation PathwayDiseaseEndosomesEnvironmentEventExcisionFamilyFunctional disorderFutureGenesGoalsImpairmentIntermediate FilamentsIntracellular TransportKnock-outKnockout MiceLightLysosomesMediatingMitochondriaModelingMovementMusMutateMutationNamesNerve DegenerationNeuritesNeurodegenerative DisordersNeurologic SymptomsNeuronsOrganellesParkinson DiseasePathogenesisPathologicPathologyPathway interactionsPeripheral Nervous SystemPhenotypePhosphorylationPlayProcessProteinsProteomicsQuality ControlRegulationReportingResearchRoleSeveritiesShapesSignal PathwaySignal TransductionSirolimusSiteSpinal GangliaStable Isotope LabelingSwellingTestingUbiquitinUbiquitinationanalogautosomecell typeearly onsetexperimental studyforgettinggiant axonal neuropathygigaxoninloss of function mutationmembermulticatalytic endopeptidase complexnervous system disorderneurofilamentneuropathologyneuroprotectionnovelprotein degradationself assemblysmall hairpin RNAsmall moleculetherapeutic targettherapy developmenttreatment strategyubiquitin ligaseubiquitin-protein ligase
项目摘要
Giant axonal neuropathy (GAN) is an early-onset, autosomal recessive neurodegenerative disease that
impacts the central and peripheral nervous systems. Pathologically, GAN is characterized by the
disorganization and aggregation of intermediate filaments (IF). Formed from self-assembling subunits, the IF
network spans the cell from the nucleus to the periphery. In GAN, many cell types show abnormalities in the
organization of IF, but neurons clearly bear the brunt of the pathology. Axons swell with the accumulation of
neuronal IF, and degenerate to cause the neurological symptoms of GAN. The gene mutated in GAN encodes
gigaxonin, a protein that belongs to the BTB/Kelch family of E3 ligase-like adaptor proteins. These proteins
typically play a role in ubiquitin-proteasome mediated protein degradation. Based on our own data that GAN
degrades neuronal IFs, we hypothesize that neurofilament aggregation creates steric roadblocks in neurites
that interfere with intracellular transport of organelles such as mitochondria and lysosomes, resulting in
downstream pathology. Furthermore, our preliminary data suggest gigaxonin plays a direct role in autophagy
via degradation of other substrates. We hypothesize that the disruption of this critical process exacerbates
GAN neuropathology by dysregulation of protein and organellar quality control. This proposal comprehensively
tests these models; thus the overall goal of our research is to understand the cellular pathogenesis of GAN
with a view to inspiring novel treatment strategies.
巨轴突神经病 (GAN) 是一种早发性常染色体隐性遗传神经退行性疾病,
影响中枢和周围神经系统。从病理学上来说,GAN 的特点是
中间丝(IF)的解体和聚集。 IF 由自组装亚基形成
网络横跨细胞从细胞核到外围。在 GAN 中,许多细胞类型表现出异常
IF 的组织,但神经元显然首当其冲。轴突随着积累而膨胀
神经元IF,并退化导致GAN的神经症状。 GAN编码中突变的基因
gigaxonin,一种属于 E3 连接酶样接头蛋白 BTB/Kelch 家族的蛋白质。这些蛋白质
通常在泛素蛋白酶体介导的蛋白质降解中发挥作用。根据我们自己的数据,GAN
降解神经元 IF,我们假设神经丝聚集在神经突中产生空间障碍
干扰线粒体和溶酶体等细胞内运输,导致
下游病理学。此外,我们的初步数据表明 gigaxonin 在自噬中发挥直接作用
通过其他底物的降解。我们假设这一关键过程的中断会加剧
通过蛋白质失调和细胞器质量控制进行 GAN 神经病理学。该提案全面
测试这些模型;因此我们研究的总体目标是了解 GAN 的细胞发病机制
以期激发新的治疗策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Puneet Opal其他文献
Puneet Opal的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Puneet Opal', 18)}}的其他基金
VEGF-Mimetic Supramolecular Nanoparticles for Treating Spinocerebellar Ataxia Type 1
VEGF 模拟超分子纳米颗粒用于治疗 1 型脊髓小脑共济失调
- 批准号:
10578485 - 财政年份:2023
- 资助金额:
$ 57.57万 - 项目类别:
Equipment Supplement: Understanding the Cellular Basis of Movement Disorders
设备补充:了解运动障碍的细胞基础
- 批准号:
10755946 - 财政年份:2023
- 资助金额:
$ 57.57万 - 项目类别:
Elucidating cellular mechanisms underlying neurodegeneration
阐明神经变性的细胞机制
- 批准号:
10435954 - 财政年份:2022
- 资助金额:
$ 57.57万 - 项目类别:
Developing novel treatment strategies for Spinocerebellar ataxia type 1
开发 1 型脊髓小脑共济失调的新治疗策略
- 批准号:
9226821 - 财政年份:2016
- 资助金额:
$ 57.57万 - 项目类别:
Understanding the Cellular Basis of Movement Disorders
了解运动障碍的细胞基础
- 批准号:
10160963 - 财政年份:2013
- 资助金额:
$ 57.57万 - 项目类别:
Understanding the cellular basis of Movement Disorders
了解运动障碍的细胞基础
- 批准号:
8719191 - 财政年份:2013
- 资助金额:
$ 57.57万 - 项目类别:
Understanding the cellular basis of Movement Disorders
了解运动障碍的细胞基础
- 批准号:
8876831 - 财政年份:2013
- 资助金额:
$ 57.57万 - 项目类别:
Understanding the Cellular Basis of Movement Disorders
了解运动障碍的细胞基础
- 批准号:
10630308 - 财政年份:2013
- 资助金额:
$ 57.57万 - 项目类别:
Understanding the cellular basis of Movement Disorders
了解运动障碍的细胞基础
- 批准号:
8631893 - 财政年份:2013
- 资助金额:
$ 57.57万 - 项目类别:
Understanding the Cellular Basis of Movement Disorders
了解运动障碍的细胞基础
- 批准号:
10403448 - 财政年份:2013
- 资助金额:
$ 57.57万 - 项目类别:
相似国自然基金
推拿“舒筋调骨”干预青少年脊柱侧弯“肌肉力学-椎间载荷”平衡机制研究
- 批准号:82374607
- 批准年份:2023
- 资助金额:51 万元
- 项目类别:面上项目
基于数字表型青少年自杀行为转化风险测度及虚拟现实矫正干预研究
- 批准号:72304244
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
青少年焦虑的预测和干预:基于跨通道恐惧泛化视角
- 批准号:32300928
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
心肺耐力对青少年执行功能影响效应及其特定脑区激活状态的多民族研究
- 批准号:82373595
- 批准年份:2023
- 资助金额:47 万元
- 项目类别:面上项目
视屏活动和CaMKII m6A甲基化修饰影响青少年抑郁症状的纵向研究
- 批准号:82304168
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Elucidating cellular mechanisms underlying neurodegeneration
阐明神经变性的细胞机制
- 批准号:
10435954 - 财政年份:2022
- 资助金额:
$ 57.57万 - 项目类别:
Regulation of hippocampal morphogenesis and homeostasis by the E3 ubiquitin ligase CRL5
E3 泛素连接酶 CRL5 对海马形态发生和稳态的调节
- 批准号:
9923017 - 财政年份:2019
- 资助金额:
$ 57.57万 - 项目类别:
Regulation of hippocampal morphogenesis and homeostasis by the E3 ubiquitin ligase CRL5
E3 泛素连接酶 CRL5 对海马形态发生和稳态的调节
- 批准号:
10089489 - 财政年份:2019
- 资助金额:
$ 57.57万 - 项目类别:
Regulation of hippocampal morphogenesis and homeostasis by the E3 ubiquitin ligase CRL5
E3 泛素连接酶 CRL5 对海马形态发生和稳态的调节
- 批准号:
10557808 - 财政年份:2019
- 资助金额:
$ 57.57万 - 项目类别:
Regulation of hippocampal morphogenesis and homeostasis by the E3 ubiquitin ligase CRL5
E3 泛素连接酶 CRL5 对海马形态发生和稳态的调节
- 批准号:
9814602 - 财政年份:2019
- 资助金额:
$ 57.57万 - 项目类别: